BIOMAT Database Logo BIOMAT Database Logo

Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns. 2003

Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Department of Medicine (Infectious Diseases), Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.

A retrospective analysis of susceptibility data on 542 blood isolates of the Bacteroides fragilis group tested from 1987 to 1999 by the same NCCLS-recommended broth microdilution method throughout is presented. Metronidazole, beta-lactam-beta-lactamase inhibitor combinations, carbapenems, and trovafloxacin were the most active agents (susceptibility of >or=93%). Among the cephalosporin-cephamycins, the order of activity was cefoxitin > ceftizoxime > cefotetan = cefotaxime = cefmetazole > ceftriaxone. All isolates were resistant to penicillin G, and 22% were resistant to clindamycin. The susceptibility rates to piperacillin-tazobactam, imipenem, and meropenem were affected least among isolates resistant to cefoxitin or clindamycin. Except for piperacillin-tazobactam, imipenem, and meropenem, the B. fragilis species was more susceptible than were the non-B. fragilis species. These data underscore the importance of susceptibility testing of the B. fragilis group and can serve as a guide in the choice of empirical antimicrobial therapy.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D001442 Bacteroides Infections Infections with bacteria of the genus BACTEROIDES. Infections, Bacteroides,Bacteroides Infection,Infection, Bacteroides
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases

Related Publications

Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.
October 1977, Medical microbiology and immunology,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Susceptibility to cefazedone and cefazolin and production of beta-lactamase in in Bacteroides fragilis and other species of Bacteroidaceae.
January 1979, Arzneimittel-Forschung,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Variation in susceptibility patterns of species within the Bacteroides fragilis group.
April 1980, Antimicrobial agents and chemotherapy,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
June 1991, Antimicrobial agents and chemotherapy,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.
December 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
January 1992, Clinical therapeutics,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
December 2004, Research in microbiology,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.
June 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
[Antimicrobial Susceptibility of Bacteroides fragilis and Bacteroides thetaiotaomicron]
November 1998, Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology,
Kenneth E Aldridge, and Deborah Ashcraft, and Megan O'Brien, and Charles V Sanders
Survey of Bacteroides fragilis group susceptibility patterns in Canada.
February 1992, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!